Related Experiment Videos
Tumor immunity and autoimmunity: a case of Dr. Jekyll and Mr. Hyde
Clinical Immunology (Orlando, Fla.)
|July 24, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Correlation of antisynthetase antibody levels with disease course in a patient with interstitial lung disease and elevated muscle enzymes.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Type I interferon as a target of treatment in SLE.
Endocrine, metabolic & immune disorders drug targets·2007
TIM-3 as a therapeutic target in anaplastic thyroid carcinoma: Preclinical and transcriptomic evidence supporting a new immunotherapy avenue.
Clinical immunology (Orlando, Fla.)·2026
Clinical immunology lessons from failed α-Synuclein and Tau immunotherapies: A roadmap for combination strategies in Alzheimer's disease.
Clinical immunology (Orlando, Fla.)·2026
Plasma anti-ATP7A/ATP7B/COPT1 autoantibodies as potential biomarkers for breast cancer detection.
Clinical immunology (Orlando, Fla.)·2026
Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis.
Clinical immunology (Orlando, Fla.)·2026
Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma.
Clinical immunology (Orlando, Fla.)·2026
T-cell activation profiles predict outcomes of neoadjuvant therapy in breast cancer.
Clinical immunology (Orlando, Fla.)·2026
Role of T Cells in Chronic Pain: Mechanisms, Regulation, and Therapeutic Implications.
Immunology and cell biology·2026
Targeting the myeloid immune checkpoint ILT3 (LILRB4) with small molecules enables reprogramming of suppressive tumor immunity.
European journal of medicinal chemistry·2026
From spatial maps to treatment decisions: a roadmap for integrating explainable AI with multi-omics to guide precision immunotherapy.
Biotechnology notes (Amsterdam, Netherlands)·2026